Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How is this a dilution scam?
Yes there were warrants and common stock issued with a lock in period until September, with an exercisable price of .50 cents. The float is still 24.7 meaning the dilution hasn’t even happened nor will it until the stock hits .50 cents a share. You people spew shit, but don’t fucking read.
So do you guys think this is gonna spike hard tomorrow?
actually I was kidding there is breaking news phase 2 results are positive and it released at the market close today.
I agree that it needs a r/s because right now there are too many shares and not enough demand. and the preferred stock doesn't get split, also for the long term it is a smart investment. the stock will tank after a r/s though for a good bit until news.
****URGENT***** Get out as fast as you can!
preferred a and b stocks issued in the new sec filing give the investor 12 million in voting power, The previous reverse split actually had majority of votes in favor for r/s, it was shut down by legalities of the company not having enough dilution in shares. If you don't believe me read these 3 quotes from each of these SEC filings.
Reverse split inevitable: https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12163257
On June 29, 2017, our Board authorized the establishment of a new series of preferred stock designated as Series B Preferred Stock, $0.01 par value, the terms of which are set forth in the certificate of designations for such series of Preferred Stock (the “Series B Certificate of Designations”) which was filed with the State of Delaware on July 5, 2017 (together with any preferred shares issued in replacement thereof in accordance with the terms thereof, the “Series B Preferred Stock”). The Series B Preferred Stock shall be entitled to the whole number of votes equal to $2.0 million divided by $0.1867 (the closing bid price on July 5, 2017, the date of execution of the securities purchase agreement of the Series B Preferred Stock), or 10,712,372 votes. The Series B Preferred Stock has no dividend, liquidation or other rights which are preferential to our common stock and may be converted into shares of our common stock at a price equal to $0.1530 per share upon the earlier of the date of closing to the extent that the holder thereof reallocates shares of our common stock reserved for issuance under its certain senior secured convertible notes (the “Notes”) to conversion of the Series B Preferred Stock and otherwise three business days after receipt of shareholder approval of a reverse split of our Common Stock for which we intend to seek shareholder approval immediately upon closing of the purchase contemplated hereby.
*********************************
Here is the majority vote for r/s: https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12133421
Votes For
Votes Against
Abstentions
Broker Non-Votes
70,127,408
37,672,937 1,517,180 -0-
*********************************
Series a preferred voting power:
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12157152
Delcath raises 2 million
http://www.drugdeliverybusiness.com/delcath-raises-2m-series-b-stock-sale/
The need for diluting stock, company knows stock is about to soar from a press release (phase 2 results) once stocks soar they will sell shares to raise capital. No investor would buy into a company that was diluted and needed capital. DCTH is about to drop their biggest bombshell in the history of the company. This week results will be published this is just my speculation.
Institutional Investors confirmed
https://cnafinance.com/delcath-systems-dcth-stock-falling-on-series-b-financing/15826
Also the 8k states that the preferred shares can be turned into a normal share but it would decrease the value from 2000 dollars a share into .15cents a share... there was only 2300 shares issued, not 2 million.
Something big is happening behind the scenes.
http://www.nasdaq.com/symbol/dcth/institutional-holdings
FDA Prohibited from owning Delcath Stocks
https://www.fda.gov/aboutfda/workingatfda/ethics/ucm079670.htm
****BREAKING*****
I was wondering why the FDA website said the clinical trial is "not available status," even though this is not one of their standard statuses. After doing some digging i realized the phase 2 trial wasn't cancelled because Delcath's website says they are completed. Prior to the status becoming "not available," the completion date was 06/28/2017. Then it hit me, they were removed for a press release. Delcath is planning an announcement within a week. Get ready for a surge. If you don't believe me here are 2 links.
Link 1 Delcath's website stating trial is completed
http://delcath.com/trial/expanded-access-study-of-melphalan-cs-php-with-delcath-system-in-patients-with-ocularcutaneous-melanoma-mets-to-liver/
Link 2: FDA website stating not available (which means they are updating it:) https://www.clinicaltrials.gov/ct2/show/results/NCT01728051?term=delcath&rank=1
Link 3: FDA known statuses for trials:
https://www.clinicaltrials.gov/ct2/show/results/NCT01728051?term=delcath&rank=1
DCTH is going to surge soon.
I found the FDA phase 2 trial that is supposed to be released by the end of this month, but they removed the completion date and submission dates... not sure if they are trying to hide something or if they are getting ready to publish info.
https://clinicaltrials.gov/ct2/show/results/NCT01728051?term=delcath&rank=1
click on No Study Results Posted
Breakout should be coming soon.
This stock is about to blow with the news and positive results.
http://investor.celsion.com/releasedetail.cfm?ReleaseID=1032105
This stock is gonna blow tomorrow Acquisition was approved.
The sale code was used to pay for taxes on a restricted stock plan. This is not a buyout sign or a dump sign. This is simply them covering assets that they owe on.
"Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3"
True but i would not play this as a long term. This is a day trade at best.
This is not fda approval for a product, this is to start clinical trials.
https://www.streetinsider.com/Corporate+News/CHF+Solutions+%28CHFS%29+Granted+FDA+IDE+Approval+for+Clinical+Study+Aquadex+FlexFlow+Aquapheresis+System+for+Pediatric+Use/13056574.html
FDA approval for clinical trials no products were actually FDA approved this is a pump and dump. What a turd of a stock.
This is gonna dip below .20 I am thinking it will hit .16 by tomorrow.
It already plummeted 2 support levels. I do believe this stock has potential but it will end in red by the end of the week.
For the cautious investors, I do not think this company is worth much, but when there is hype and media attention I see it as a way to make easy money off of other people's stupidity. So I think most people on the board realize that we are investing in hype, not the company. The hype is what makes fast easy money, not the company.
DCTH will be releasing news about the phase 2 trials very soon don't forget.
There are lots of big buys EoD tomorrow will start green confirmed.
does tomorrow start as a red day or a green day?
The Final Push is coming in the next 45 minutes
it looks like we have big fish looking at this stock....
https://twitter.com/timothysykes
Timothy Sykes?Verified account @timothysykes 11h11 hours ago
More
https://profit.ly/500ElK - Posted a New Webinar: Challenge Webinar 6-22 [On Demand] $DCTH $OMER
@Jayzee4 I know you are trying to be optimistic but those publications are over a year old. What we need is current news.
The results for phase 2 are in but they have not been published yet. According to the fda website they will be posted by august 1st.
Phase 2 results will be here soon
Estimated Enrollment: 42
Study Start Date: June 2014
Estimated Study Completion Date: August 2016
Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
Estimated Enrollment: 31
Study Start Date: October 2014
Estimated Study Completion Date: August 2016
Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)
https://clinicaltrials.gov/ct2/show/NCT02406508?term=NCT+02406508&rank=1
https://clinicaltrials.gov/ct2/show/NCT02415036?term=NCT+02415036&rank=1
Possible Press release Monday according to some rumors from StockTwits. Phase 2 Trial reports? There is lots of movement of people buying on this forum. Proceed with Caution.
https://stocktwits.com/symbol/DCTH